within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G04B_Urologicals.G04BD06_Propiverine;
model Propiverine 
   extends Pharmacolibrary.Drugs.ATC.G.G04BD06;

  annotation(Documentation(
    info ="<html><body><p>Propiverine is an antimuscarinic drug used for the treatment of overactive bladder and urinary incontinence. It acts by inhibiting acetylcholine on smooth muscle in the urinary bladder. The drug is approved and currently used in clinical practice for management of urinary frequency, urgency, and urge incontinence.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after single oral administration.</p><h4>References</h4><ol><li><p>Yamada, S, et al., &amp; Yoshida, K (2010). The N-oxide metabolite contributes to bladder selectivity resulting from oral propiverine: muscarinic receptor binding and pharmacokinetics. <i>Drug metabolism and disposition: the biological fate of chemicals</i> 38(8) 1314–1321. DOI:<a href=&quot;https://doi.org/10.1124/dmd.110.033233&quot;>10.1124/dmd.110.033233</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20483954/&quot;>https://pubmed.ncbi.nlm.nih.gov/20483954</a></p></li><li><p>Siepmann, M, et al., &amp; Kirch, W (1998). Pharmacokinetics and safety of propiverine in patients with fatty liver disease. <i>European journal of clinical pharmacology</i> 54(9-10) 767–771. DOI:<a href=&quot;https://doi.org/10.1007/s002280050549&quot;>10.1007/s002280050549</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9923582/&quot;>https://pubmed.ncbi.nlm.nih.gov/9923582</a></p></li><li><p>May, K, et al., &amp; Siegmund, W (2008). Oral absorption of propiverine solution and of the immediate and extended release dosage forms: influence of regioselective intestinal elimination. <i>European journal of clinical pharmacology</i> 64(11) 1085–1092. DOI:<a href=&quot;https://doi.org/10.1007/s00228-008-0528-0&quot;>10.1007/s00228-008-0528-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18626633/&quot;>https://pubmed.ncbi.nlm.nih.gov/18626633</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Propiverine;
